Picosulfuric acid
As of the edition of 20 October 2026, Picosulfuric acid is a small molecule: marketed, first approved in 1968 (ES).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2016
- Kind
- Small molecule
- Brand name
- Prepopik
- First approved
- 1 May 1968 (ES)
- Approvals on record
- 6 in 5 regions
- Holder of the most recent approval
- Ferring Pharmaceuticals; 3 holders in all
- Registered trials
- 27, 1 stopped early
- Disease areas
- Digestive system; Cancer; Infections; Injuries; Mental health; Nutrition and metabolism
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 6 | 3 | 0 | 0 |
| Phase 1 | 2 | 1 | 1 | 0 |
| Phase 2 | 3 | 1 | 2 | 0 |
| Phase 3 | 6 | 6 | 0 | 0 |
| Phase 4 | 10 | 5 | 1 | 1 |
| All trials | 27 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Ferring Pharmaceuticals | Applicant and Lead sponsor of trials | 2004 to now |